Mercaptomerin

  • (3-(((3-Carboxy-2,2,3-trimethylcyclopentyl)
  • (Carbonyl)amino)-2-methoxypropyl)(mercaptoacetato-s)mercury disodium salt
  • Disodium n(3-(Carboxymethylthiomercuri)-2-methoxypropyl)-alpha-Camphoramate
  • Sodium mercaptomerin
  • Diucardyn sodium
  • Mercaptomerine
Formula
C16H25HgNO6S . 2H
Structure
Uses
Medication.

Registry Numbers and Inventories.
CAS
20223-84-1
RTECS
OV8600000
RTECS class
Mutagen
UN (DOT)
2025
Beilstein/Gmelin
1078733
RCRA
D009

Properties.
Formula
C16H27HgNO6S
Formula mass
562.05
Melting point, °C
190 - 191

Hazards and Protection.
Storage
Keep in a cool, dry, dark location in a tightly sealed container or cylinder. Keep away from incompatible materials, ignition sources and untrained individuals. Secure and label area. Protect containers/cylinders from physical damage.
Handling
All chemicals should be considered hazardous. Avoid direct physical contact. Use appropriate, approved safety equipment. Untrained individuals should not handle this chemical or its container. Handling should occur in a chemical fume hood.
Protection
Wear appropriate protective gloves, clothing and goggles.
Respirators
Wear positive pressure self-contained breathing apparatus (SCBA).
Small spills/leaks
Do not touch damaged containers or spilled material unless wearing appropriate protective clothing. Stop leak if you can do it without risk. Cover with plastic sheet to prevent spreading. Absorb or cover with dry earth, sand or other non-combustible material and transfer to containers. DO NOT GET WATER INSIDE CONTAINERS.
Stability
No data.

Fire.
Fire fighting
Use method most appropriate to fight surrounding fire.
Fire potential
Non-Combustible
Combustion products
Fire may produce irritating, corrosive and/or toxic gases.

Health.
Exposure effects
in overdose lethargy and coma have been reported in children ingesting thiazide diuretics. Altered mental status, headache, hypertonia, muscle weakness, and seizures may develop secondary to diuretic-induced electrolyte abnormalities. Ototoxicity occurs rarely and is usually reversible.
   Ingestion
Dry mucous membranes suggest dehydration. GI bleeding may occur during therapy with ethacrynic acid and furosemide, particularly in patients with renal failure. Abuse or overdose may result in abdominal distention, hyperperistalsis and flatus. Pancreatitis has been reported but is rare.
   Inhalation
Noncardiogenic pulmonary edema after hydrochlorothiazide ingestion has been reported and is believed to be an idiosyncratic reaction.
   Skin
Avoid any skin contact. See Inhalation.
   Eyes
See Inhalation.

First aid
 
   Ingestion
Seek medical assistance.
   Inhalation
Move victim to fresh air. Apply artificial respiration if victim is not breathing. Do not use mouth-to-mouth method if victim ingested or inhaled the substance; induce artificial respiration with the aid of a pocket mask equipped with a one-way valve or other proper respiratory medical device. Administer oxygen if breathing is difficult.
   Skin
Flush skin with plenty of soap and water for at least 15 minutes while removing contaminated clothing and shoes.
   Eyes
Immediately flush with running water for at least 20 minutes.

Transport.
UN number
2025
Response guide
Hazard class
6.1
Packing Group
I; II; III